Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. RAPT Therapeutics Inc shares valued at $20,456 were sold by Brockstedt Dirk G. on Jan 05 ’24. At $22.78 per share, Brockstedt Dirk G. sold 898 shares. The insider’s holdings dropped to 27,820 shares worth approximately $0.22 million following the completion of this transaction.
Also, HO WILLIAM sold 2,500 shares, netting a total of over 54,200 in proceeds. Following the sale of shares at $21.68 each, the insider now holds 15,020 shares.
Before that, HO WILLIAM had sold 1,500 shares from its account. In a trade valued at $20,580, the Chief Medical Officer traded RAPT Therapeutics Inc shares for $13.72 each. Upon closing the transaction, the insider’s holdings decreased to 1,500 shares, worth approximately $0.14 million.
As published in a research note from UBS on February 22, 2024, RAPT Therapeutics Inc [RAPT] has been rated down from a Buy to a Neutral and the price target has been revised to $10 from $61. Analysts at Leerink Partners downgraded the stock from ‘”an Outperform”‘ to ‘”a Market perform”‘ outlook in a report released in late February. As of February 21, 2024, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for RAPT. Earlier on February 21, 2024, H.C. Wainwright downgraded its rating. Their new recommendation was “a Neutral” for RAPT stock which previously was a “a Buy”.
Analyzing RAPT Stock Performance
During the last five days, there has been a drop of approximately -10.86%. Over the course of the year, RAPT Therapeutics Inc shares have dropped approximately -67.65%. Shares of the company reached a 52-week high of $27.35 on 02/12/24 and a 52-week low of $6.86 on 02/20/24. A 50-day SMA is recorded $11.69, while a 200-day SMA reached $17.15. Nevertheless, trading volume fell to 0.71 million shares from 1.11 million shares the previous day.
Support And Resistance Levels for RAPT Therapeutics Inc (RAPT)
According to the 24-hour chart, there is a support level at 7.88, which, if violated, would cause prices to drop to 7.73. In the upper region, resistance lies at 8.25. The next price resistance is at 8.47. RSI (Relative Strength Index) is 37.62 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.26, which suggests the price will decrease in the coming days. Percent R is at 87.05%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
